Funds innovative cardiac surgery research on novel devices and approaches to improve outcomes in heart failure due to heart disease.
Funder: Thoracic Surgery Foundation for Research and Education
Due Dates: September 15, 2026
Funding Amounts: $40,000 per year for up to 2 years (maximum $80,000 total)
Summary: Supports cardiac surgeons, trainees, and scientists developing innovative devices or approaches to improve outcomes in heart failure secondary to heart disease.
This award, named in honor of surgeon-inventor Arshad Quadri and aortic surgery innovator Joseph Bavaria, is designed to advance innovation in cardiac surgery. It funds research projects that focus on basic, pre-clinical, or translational studies addressing heart failure due to heart disease, especially through the development and evaluation of novel devices. Projects may include research on heart valve device design, function, physiology, and efficacy, aiming to reduce the burden of end-stage valvular or other cardiac conditions.